KLF13 and congenital heart disease: Deletion of KLF-13 (as well as other GATA4 modifier factors) has been associated with congenital heart defects, including Holt–Oram syndrome (discussed in a subsequent section), atrial and septal malformations, and ventricular hypotrabeculation [36].